Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.
    Benzinga,  Biotechnology,  Health,  Nature,  Regenerative Medicine

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022 /

    Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market  is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …

    read more
    Jessica N. Abraham Comments Off on Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    You May Also Like

    Derivative trading, options trading, CFD, Contract for Derivatives, Trading stocks, Crypto trading, Leveraging margin

    A Look into Share CFDs and the Top 5 to Watch… Come Rise or Fall

    October 4, 2021
    VUZIX M400 Product #: 472T00011 First smart glasses with a dedicated XR1 platform Lightweight, comfortable fit that you can wear all day The only option that lets you hot swap batteries on the fly with zero interruption Increased processing power, RAM, and storage Upgraded OLED panel display and camera with higher resolution and scanning Immersive UI with native voice processing, motion tracking, and more

    Vuzix | Will the Next Big Trend in Wearables be Smart Glasses?

    June 28, 2021
    These 5 altcoins should help everyone weather Crypto winter.

    5 Coins on the Ethereum Blockchain to Watch During This Altcoin Cycle

    June 3, 2020
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.